Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne-Laure Sennesael

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 1, 2018
Glucose-regulated protein of 94 kDa contributes to the development of an aggressive phenotype in breast cancer cellsPedro Buc Calderon, Anne-Laure Sennesael, Christophe Glorieux
Thrombosis Research|January 24, 2020
Do computerized clinical decision support systems improve the prescribing of oral anticoagulants? A systematic reviewAnne-Laure Sennesael, Bruno Krug, Barbara Sneyers, et al.
International Journal of Clinical Pharmacy|November 25, 2017
Implementing a screening tool to improve prescribing in hospitalized older patients: a pilot studyAnne-Laure Sennesael, Olivia Dalleur, Séverine Henrard, et al.
Scientific Reports|July 14, 2018
Effect of ABCB1 genetic polymorphisms on the transport of rivaroxaban in HEK293 recombinant cell linesAnne-Laure Sennesael, Nadtha Panin, Christelle Vancraeynest, et al.
Frontiers in Cardiovascular Medicine|April 15, 2022
Uninterrupted DOACs Approach for Catheter Ablation of Atrial Fibrillation: Do DOACs Levels Matter?Michael Hardy, Jonathan Douxfils, Anne-Sophie Dincq, et al.
Research and Practice in Thrombosis and Haemostasis|September 4, 2024
<i>In vitro</i> assessment of the risk of ABCB1-mediated drug-drug interaction between rivaroxaban and tacrolimus in human embryonic kidney 293 recombinant cell linesGwenaëlle Mahieu, Anne-Laure Sennesael, Lionel Pochet, et al.
The American Journal of Medicine|June 28, 2021
The Impact of Strong Inducers on Direct Oral Anticoagulant LevelsAnne-Laure Sennesael, Anne-Sophie Larock, Philippe Hainaut, et al.
The Annals of Pharmacotherapy|July 2, 2014
Appropriateness of prescribing dabigatran etexilate and rivaroxaban in patients with nonvalvular atrial fibrillation: a prospective studyAnne-Sophie Larock, François Mullier, Anne-Laure Sennesael, et al.
Drugs & Aging|July 10, 2020
Medication Counselling in Older Patients Prior to Hospital Discharge: A Systematic ReviewAndreas Capiau, Katrien Foubert, Lorenz Van der Linden, et al.
British Journal of Clinical Pharmacology|March 10, 2018
Preventability of serious thromboembolic and bleeding events related to the use of oral anticoagulants: a prospective studyAnne-Laure Sennesael, Anne-Sophie Larock, Bérangère Devalet, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 1, 2018
Glucose-regulated protein of 94 kDa contributes to the development of an aggressive phenotype in breast cancer cellsPedro Buc Calderon, Anne-Laure Sennesael, Christophe Glorieux
Thrombosis Research|January 24, 2020
Do computerized clinical decision support systems improve the prescribing of oral anticoagulants? A systematic reviewAnne-Laure Sennesael, Bruno Krug, Barbara Sneyers, et al.
International Journal of Clinical Pharmacy|November 25, 2017
Implementing a screening tool to improve prescribing in hospitalized older patients: a pilot studyAnne-Laure Sennesael, Olivia Dalleur, Séverine Henrard, et al.
Scientific Reports|July 14, 2018
Effect of ABCB1 genetic polymorphisms on the transport of rivaroxaban in HEK293 recombinant cell linesAnne-Laure Sennesael, Nadtha Panin, Christelle Vancraeynest, et al.
Frontiers in Cardiovascular Medicine|April 15, 2022
Uninterrupted DOACs Approach for Catheter Ablation of Atrial Fibrillation: Do DOACs Levels Matter?Michael Hardy, Jonathan Douxfils, Anne-Sophie Dincq, et al.
Research and Practice in Thrombosis and Haemostasis|September 4, 2024
<i>In vitro</i> assessment of the risk of ABCB1-mediated drug-drug interaction between rivaroxaban and tacrolimus in human embryonic kidney 293 recombinant cell linesGwenaëlle Mahieu, Anne-Laure Sennesael, Lionel Pochet, et al.
The American Journal of Medicine|June 28, 2021
The Impact of Strong Inducers on Direct Oral Anticoagulant LevelsAnne-Laure Sennesael, Anne-Sophie Larock, Philippe Hainaut, et al.
The Annals of Pharmacotherapy|July 2, 2014
Appropriateness of prescribing dabigatran etexilate and rivaroxaban in patients with nonvalvular atrial fibrillation: a prospective studyAnne-Sophie Larock, François Mullier, Anne-Laure Sennesael, et al.
Drugs & Aging|July 10, 2020
Medication Counselling in Older Patients Prior to Hospital Discharge: A Systematic ReviewAndreas Capiau, Katrien Foubert, Lorenz Van der Linden, et al.
British Journal of Clinical Pharmacology|March 10, 2018
Preventability of serious thromboembolic and bleeding events related to the use of oral anticoagulants: a prospective studyAnne-Laure Sennesael, Anne-Sophie Larock, Bérangère Devalet, et al.
Pageof 2